昆藥集團(600422.SH)擬在昭通新設子公司實施互聯網+4+N戰略路徑
格隆匯10月20日丨昆藥集團(600422.SH)公佈,為進一步加大對醫療終端的覆蓋,夯實現有終端與品種資源基礎,加快戰略實施、加快市場拓展,在鞏固和提升醫療版塊發展的同時,充分利用昆藥商業OTC一級代理與子公司物流配送優勢,孕育、發展OTC終端業務,實施昆藥商業互聯網+4+N戰略路徑,實現昆藥商業成為區域內完整醫藥流通方案解決者的戰略願景,昆藥商業擬在昭通新設全資子公司。公司名稱暫定為”昆藥商業(昭通)醫藥有限公司”,註冊資本及出資方式:人民幣1,000萬元整,現金認繳出資,實際出資進度根據公司經營需求分期出資。
昭通公司經營範圍(暫定):藥品、醫療器械、醫療用品及器材、保健食品、預包裝食品、消毒用品、消毒器械、化粧品及衞生用品、日用百貨的銷售、配送服務;貨物或技術進出口;倉儲服務;普通貨物道路運輸;醫藥信息諮詢服務;會議及展覽服務;廣告的設計、製作、代理、發佈;計算機系統集成及綜合佈線。
此事項由公司九屆十五次董事會會議審議通過,無需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.